These patents cover, among other things, posterior placement of an implant in a facet joint using a chisel and guide tube; placement of an implant in a facet joint using a forked guide tube; placement of implants of various configurations in a cervical facet joint; and distraction of a facet joint after posterior placement of an implant in the facet joint.
These four recent issuances bring the number of issued patents in Providence’s growing patent portfolio to 35 total. Providence has already filed approximately 40 other applications in various stages of prosecution in the United States and overseas covering various aspects of its proprietary technologies.
“We have invested tremendous resources over the years in filing both broad and detailed disclosures covering the important aspects of our technology for tissue-sparing posterior cervical and spinal intervention,” said Jeff Smith, Providence Medical CEO. “We are extremely pleased with the continued and accelerating growth of our patent portfolio as it provides the means to protect our innovations and rapidly expanding business.”
Providence Medical Technology is a privately-held firm developing technological solutions for cervical spinal conditions. The company has pioneered a proprietary, tissue-sparing approach to posterior cervical fusion. Providence has developed surgical instrumentation and implants that offer unique benefits in the $2 billion worldwide cervical spine market. The Providence family of products includes the DTRAX Spinal Instrumentation System, CAVUX intervertebral implants, and the ALLY line of bone and facet screws. The company is based in Walnut Creek, Calif.